Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHAMP UK: Low-dose atropine eye drops to reduce progression of myopia in children
2017-004108-23Phase 2Unknown
- Sponsor
- Belfast Health and Social Care Trust
- Start
- Aug 2018
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in myopia comparing Low-dose atropine 0.01% with Placebo (2 arms). Primary endpoint: Spherical equivalent refractive error at 24 months. Status: unknown.
02
Drugs
atropine
03
Conditions
myopia
Beyond the preview
Go deeper on 2017-004108-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-004108-23.